Role of chemotherapy in resectable liver metastases from colorectal cancer: food for thought from pooled evidence
Open Access
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Postoperative chemotherapy with single-agent fluoropyrimidines after resection of colorectal cancer liver metastases: a meta-analysis of randomised trialsESMO Open, 2018
- Oral adjuvant chemotherapy using uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: Long-term survival results of the phase III UFT/LV study.Journal of Clinical Oncology, 2017
- Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA studyNeoplasia, 2017
- FOLFOX or XELOX as adjuvant therapy after curative resection of metastatic or relapsed colorectal cancerAnnals of Oncology, 2016
- Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trialBMC Cancer, 2015
- Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trialThe Lancet Oncology, 2014
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialThe Lancet Oncology, 2013
- Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines CureJournal of Clinical Oncology, 2007
- Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 TrialJournal of Clinical Oncology, 2006
- Colorectal metastasis (liver and lung)Surgical Clinics of North America, 2002